Search clinical trials for: Clindamycin and Dapsone gel for 03 months

Total 450 results

Jinnah Postgraduate Medical Centre

Completed

Comparison of the Efficacy of Clindamycin Phosphate 1% Gel Versus Once-daily Dapsone 5% Gel in the Treatment of Moderate Acne Vulgaris

Acne Vulgaris

Pakistan
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

Acne Vulgaris

United States
Actavis Inc.

Completed

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Acne Vulgaris

United States
GlaxoSmithKline

Completed

W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel

Acne Vulgaris | Acne

United States, Canada, Belize
Stiefel, a GSK Company
GlaxoSmithKline; Quintiles, Inc.; Rho, Inc.

Completed

Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne

Acne Vulgaris

United States, Canada, Belize
Wake Forest University Health Sciences
Bausch Health Americas, Inc.

Not yet recruiting

Experience With Topical Acne Treatment

Acne

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

Acne Vulgaris

United States
Torrent Pharmaceuticals Limited
Catawba Research

Completed

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize
Allergan

Completed

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

Acne Vulgaris

United States
Zydus Lifesciences Limited

Completed

To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel

Acne Vulgaris

United States, India
Padagis LLC

Completed

Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris

Acne

United States
Watson Laboratories, Inc.

Completed

Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
University of Southern California

Completed

Topical Treatment and Prevalence of P. Acnes

Surgical Site Infection

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
GlaxoSmithKline

Completed

A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris

Acne Vulgaris

China
Almirall, S.A.
Allergan

Completed

Phototoxicity Test of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Almirall, S.A.
Allergan

Completed

Photoallergy Potential of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Almirall, S.A.
Allergan

Completed

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Acne Vulgaris

United States, Canada
Padagis LLC

Completed

A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris

Acne
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne

Acne Vulgaris

United States
Padagis LLC

Completed

Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Akorn, Inc.

Completed

Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize
University of Nebraska
Biogen

Completed

The Effect of Exercise on Strength and Mobility and Corresponding CNS Plasticity in Multiple Sclerosis Patients (remapping)

Multiple Sclerosis

United States
Daré Bioscience, Inc.

Completed

DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)

Bacterial Vaginosis

United States
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.

Acne Vulgaris

United States, Belize
Stiefel, a GSK Company
GlaxoSmithKline

Completed

W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers

Acne Vulgaris
Callender Center for Clinical Research
Society Hill Dermatology

Unknown

Efficacy & Safety of Clindamycin and Tretinoin in Acne

Acne

United States
Almirall, S.A.
Allergan

Completed

Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Acne Vulgaris

United States, Canada
Taro Pharmaceuticals USA

Completed

A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
All India Institute of Medical Sciences, Bhubaneswar

Completed

Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris

Acne Vulgaris

India
All India Institute of Medical Sciences, New Delhi
Sanjay Gandhi Postgraduate Institute of Medical Sciences; Christian Medical...

Completed

Treatment Duration for Abdominal Tuberculosis (RNTCP-DOTS)

Tuberculosis

India
Lee's Pharmaceutical Limited
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

China
Taro Pharmaceuticals USA

Completed

Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Massachusetts General Hospital
Medicis Pharmaceutical Corporation

Completed

Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea

Rosacea

United States
Allergan

Completed

Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris

Acne Vulgaris

United States
Allergan

Completed

A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.

Rosacea

United States
Vanderbilt University Medical Center

Terminated

Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis

Dermatitis Herpetiformis

United States
Zeichner, Joshua, M.D.

Unknown

Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

Dermal Tolerability of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Zeichner, Joshua, M.D.

Unknown

A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications

Acne Vulgaris

United States
Galderma R&D

Completed

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne

Acne Vulgaris
Allergan

Withdrawn

An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris

Acne Vulgaris
Sanofi

Completed

A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.

Acne Vulgaris
Seegpharm S.A.

Completed

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize

3

Subscribe